A team of cell biologists, toxicologists and molecular
bioscientists at UC Davis has published a study connecting
thimerosal with disruptions in antigen-presenting cells
known as dendritic cells obtained from mice. The study
provides the first evidence that dendritic cells show
unprecedented sensitivity to thimerosal, resulting in
fundamental changes in the immune system's ability to
respond to external factors. The study was published online
today and will be available in the July print edition of
Environmental Health Perspectives, the peer-reviewed
scientific publication of the National Institute of
Environmental Health Sciences.
"This is the first time that thimerosal has been shown to
selectively alter the normal functions of dendritic cells,"
said Isaac Pessah, a toxicologist with the UC Davis School
of Veterinary Medicine, director of the Children's Center
for Environmental Health and Disease Prevention and senior
author of the study. "Dendritic cells play pivotal roles in
overcoming viral and bacterial invaders by coordinating the
immune system's overall combat response." One dendritic cell
can activate as many as 300 T-cells - white blood cells that
help find and kill external agents that attack the immune
system - making them the most effective immune system
activators.
The study shows how intricate connections between calcium
channels in dendritic cells change when exposed to
thimerosal.
"The slightest fluctuation in how calcium channels
'communicate' can alter the growth, maturation and
activation of dendritic cells," explained Pessah.
"Thimerosal dramatically alters how two key calcium
channels, code-named RyR1 and IP3R1, found in dendritic
cells function as a team by 'garbling' the normal signaling
system between them."
When thimerosal, at a concentration as low as 20 parts per
billion, alters the fidelity of normal calcium signals,
dendritic cells show abnormal secretion of IL-6 cytokine - a
potent chemical signal that initiates inflammatory
responses. Higher concentrations - 200 parts per billion -
causes programmed death of dendritic cells, preventing them
from maturing and doing their primary job of activating
T-cells. Without proper feedback to guide its response, a
normal dendritic cell can quickly become "a rogue, producing
misinformation that could activate aberrant and harmful
immune responses," Pessah explained. "Even one rogue
dendritic cell can activate many inappropriate immune
responses."
The research team conducted the study on cells cultured from
a strain of mouse not particularly susceptible to immune
dysregulation. Using fluorescent stains and powerful
microscopes to study both immature and mature dendritic
cells from bone marrow cultured under normal physiological
conditions, the researchers discovered that extremely small
levels of thimerosal interfere significantly with calcium
channel function after just a few minutes of exposure. They
also observed that immature dendritic cells are particularly
sensitive to thimerosal.
Thimerosal is a cheap and effective mercury-based
preservative. Its potential effects on embryonic neuron
development led to its removal from many pediatric vaccines.
However, it is still used in influenza, diphtheria and
tetanus vaccines, blood products and many over-the-counter
pharmaceuticals. The concentrations of thimerosal used by
the UC Davis researchers were comparable to those attained
in childhood vaccinations containing the preservative.
Researchers and parents have previously proposed links
between childhood vaccines and autism, a neurodevelopmental
disorder that affects language skills and social
interactions. The UC Davis study indicates that in addition
to being a direct neurotoxicant, thimerosal may also be an
immunotoxicant, leaving the immune system vulnerable to
microbes and other external influences.
"Our findings do not directly implicate thimerosal as a
single causative agent for triggering neurodevelopmental
disorders such as autism," Pessah said. "There is growing
evidence that autism is several disorders that we now refer
to as just one. There is also growing evidence that some
children with autism have unique immune cell composition and
responses to antigens. The results of our work provide a
framework to test the hypothesis that the genetic background
of some individuals may render them especially susceptible
to thimerosal."
Other experts also advise drawing no final conclusions
regarding thimerosal and autism based on these outcomes.
"These findings should be interpreted cautiously. Although
they suggest that thimerosal may affect dendritic cell
function, the pathophysiological consequences of thimerosal
remain unclear," said David A. Schwartz, a physician and
director of the National Institute of Environmental Health
Sciences.
Since cell functions can differ across organisms, Pessah
will next study dendritic cells isolated from the blood of
children with and without autism to confirm if the
intercellular changes are the same in humans. The initial
mouse study was funded by the National Institute of
Environmental Health Sciences and the UC Davis M.I.N.D.
Institute. Joining Pessah on the scientific team were
molecular bioscientists Samuel R. Goth, Ruth A. Chu and
Gennady Cherednichenko and pathologist Jeffrey P. Gregg.
A copy of "Uncoupling of ATP-mediated Calcium Signaling and
Dysregulated IL-6 Secretion in Dendritic Cells by Nanomolar
Thimerosal" can be downloaded at
http://www.ehponline.org/docs/2006/8881/abstract.html.
The NIEHS-funded Center for Children's Environmental Health
and Disease Prevention is a multi-disciplinary research
organization established to examine how toxic chemicals may
influence the development of autism in children. The
center's goal is to contribute knowledge about autism that
will lead to new prevention and treatment strategies. For
more information, visit www.vetmed.ucdavis.edu/cceh. The UC
Davis M.I.N.D. (Medical Investigation of Neurodevelopmental
Disorders) Institute is a unique collaborative center
bringing together parents, scientists, clinicians and
educators for research on autism and other
neurodevelopmental disorders. For more information, visit
www.mindinstitute.org .